HIV/TB Integration in a Network of Voluntary Counseling/Testing Centers in HAITI Reynold Grand’Pierre MD, Marie Suze Jacquet MD, Jean W. Pape MD PEPFAR.

Slides:



Advertisements
Similar presentations
Part A/Module A1/Session 4 Part A: Module A1 Session 4 Comprehensive Care for People Living with HIV/AIDS (PLHA)
Advertisements

The effect of changes in Kenya HIV guidelines on proportion of patients on ART and patient characteristics at initiation in Lumumba Health Centre, Western.
TB and HIV: Tightly Linked… and Why We Should Care.
High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa – Implications for HIV and TB Treatment Programs Kogieleum Naidoo on behalf.
The South African Cryptococcal Screening Program: Program update XIX international AIDS Conference Washington United States 24 th July 2012 Dr. Samuel.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Launch of Revised Strategy of TB- HIV Cross Referrals Delhi State AIDS Control Society Govt. of Delhi By Dr A.K. Gupta MD (Pediatrics) Additional Project.
U. S. Senate Briefing World TB Day Celine Gounder, MD, ScM Center for TB Research, Johns Hopkins University Director for Delivery, CREATE On behalf of.
HIV and TB Co-infection North Dakota HIV Symposium May 19, 2010 David McNamara, M.D. Clinical Assistant Professor of Medicine University of North Dakota.
In the name of God Fariba Rezaeetalab Assistant Professor.
Paul Farmer, MD, PhD Partners In Health Harvard Medical School Brigham and Women’s Hospital Social Analysis 76 Global Health Challenges 8 November 2006.
Module 6: Routine HIV Testing of TB Patients. Learning Objectives Explain why TB suspects and patients should be routinely tested for HIV Summarize the.
Unit 5: IPT Isoniazid TB Preventive Therapy
Chronic HIV Infection Clinical Manifestations Opportunistic Infections O.I. Prophylaxis.
 Pulmonary Tuberculosis BY: MOHAMED HUSSEIN. Cause  Caused by Mycobacterium tuberculosis (M. tuberculosis)  Gram (+) rod (bacilli). Acid-fast  Pulmonary.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
A cost-effectiveness evaluation of preventive interventions for HIV-TB in Sub-Saharan Africa (Tanzania): Relevance for neurological infections Lucie Jean-Gilles.
HIV in Suriname Ministry of Health Suriname M.Sigrid Mac Donald – Ottevanger, MD Focal point HIV Treatment and Care, NAP.
HAIVN Harvard Medical School AIDS Initiative in Vietnam
Downloaded from Accelerate scaling up of TB/HIV activities in Tanzania Dr. N.G.SIMKOKO WHO/NTLP - Tanzania.
IMPLEMENTATION PLAN TO SCALE UP HIV/AIDS PREVENTION AND TREATMENT 1.
Challenges of service integration: the TB model Linda-Gail Bekker The Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, South.
Johns Hopkins Center for Tuberculosis Research
Group Discussion Guyana, The Bahamas T & T, Jamaica Barbados, Haiti Suriname, Curacao.
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
1 Psychosocial Issues Faced by PLHIV HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Progress of the Singapore TB Elimination Programme (STEP)
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
TB/HIV management survey  Baseline audit in parallel with guidelines development process  Survey of clinician opinion and practice  Data collection.
Scaling-up male circumcision programmes in the Eastern and Southern Africa Region Country update meeting HIV Testing and Counseling and Male Circumcision.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Improving access to HIV testing and other basic health services in rural areas of Malawi through mobile clinics E.S. Schell, RN, PhD, FAAN; A. Bvumbwe,
TB-HIV INTEGRATION IN THE WORKPLACE 2 nd Private Sector Conference on HIV and AIDS Presenter: Dr S Charalambous.
HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Colleen Daniels Stop TB Department World Health Organisation TB, HIV and Drug Use The overview.
Tuberculosis August 17, 2010 Tuberculosis Mycobacterium tuberculosis – Fastidious, aerobic, acid-fast bacillus Tremendous increase in incidence over.
Prophylaxis of Opportunistic Infections
Q1 Which of the following descriptions about HIV and TB interaction is right ? Which of the following descriptions about HIV and TB interaction is right.
1 GH Friedland, MD Tuberculosis and HIV Models for TB programmes to contribute to the delivery of ART What are the operational research questions? Gerald.
AIDS 2014 Workshop on increasing access to TB services as part of integrated care for people who inject drugs Integrating TB services.
Integration of TB and HIV Screening, Care and Treatment in Mulago Hospital, Uganda Rhoda Wanyenze, Doris Mwesigire, Henry Luzze, Violet Gwokyalya, Julius.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
HIV Testing for TB Patients in the Context of ART Scale-Up - Barriers to Implementation Kevin M. De Cock, MD CDC Kenya Geneva, February 14, 2005.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
TB AND HIV/AIDS THE SITUATION AT BMC Care & Treatment Unit CME, 5/5/20166 PRESENTERS: Dr. Desideris Bernard, Dr. Magawa.
Treatment Regimens for Pulmonary Tuberculosis Caused by Drug- Susceptible Organisms Initial PhaseContinuation Phase RegimenDrugs Interval and Doses (Minimal.
TB-H V Co-infection by Dr. Ker Hong Bee 11. LEARNING OBJECTIVES To know & understand about TB-HIV co- infection in relation to:- – interaction & prevalence.
More Than Just a Cut: Voluntary Medical Male Circumcision Programs Can Address Low HIV Testing and Counseling Usage and ART Enrollment among Young Men:
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
Tuberculosis and HIV: Approaches to diagnosis, treatment and prophylaxis. Jean Wiliam Pape MD Professor of Medicine Division of International Medicine.
2007 HIV/AIDS Implementers’ Meeting Kigali, Rwanda Roadmap to TB/HIV sessions Saturday June 16, :30 to 17:00-Serena Auditorium: Concurrent Breakout.
Sarah Al-Obaydi M.B.Ch.B, MPH(c) Fulbright scholar.
Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
Advances in care and treatment of AIDS, TB and other OIs through research capacity building in Haiti JEAN WILLIAM PAPE, MD Howard and Carol Holtzmann Professor.
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Progress in Implementation of TB/HIV Collaborative activities
Enablers for nationwide expansion of collaborative TB/HIV activities
UNAIDS/WHO POLICY ON HIV TESTING June 2004
Tb: Screening & Diagnosis (1)
Anthony D Harries Ministry of Health, Malawi
Improving the Use of Medications to Treat Complex Health Problems in Resource-Poor Settings: Community-Based Examples from Haiti and Peru Jennifer Furin,
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
TB Screening and Differentiated Service Delivery: State of the Art
Presentation transcript:

HIV/TB Integration in a Network of Voluntary Counseling/Testing Centers in HAITI Reynold Grand’Pierre MD, Marie Suze Jacquet MD, Jean W. Pape MD PEPFAR Meeting Kigali, Rwanda June 16, 2007

Timeline of HIV Disease in Haiti Before ART: Most important OIs Pulmonary TB : most common pre-AIDS manifestation occurring in 40% of the cohort by 6 years Most common AIDS illness: wasting syndrome, candida esophagitis, coccidia diarrhea Leading causes of death : wasting syndrome, TB, crytococcal meningitis, toxoplasmosis Deschamps MM et al. AIDS. 2000, 14:

STI Management Post-HIV exposure Counseling and HAART Pre-test Counseling HIV, Syphilis, Tuberculosis, Malaria Post-Test Counseling Same day TB screening / Rx / Px Care to HIV infected individual / affected family  OI Rx/Px  HAART for AIDS or CD4 count  200  Nutritional support  Psychosocial support Reproductive Health Services (family planning and prenatal care) HIV+ women Prevention HIV MTCT with HAART Cornell-GHESKIO VCT model with integrated services Rx = Treatment Px = Prophylaxis Peck R, Fitzgerald D, Liautaud B et al: JAIDS:33; , 2003

PIH “Zanmi la sante” GHESKIO Centers National Plan for Expansion of Care and Prevention

Screening for TB at HIV VCT Centers Study to evaluate risk of having TB among clients with cough seeking HIV testing at voluntary counseling and testing centers (VCTs). Active TB was diagnosed in: –30% of all VCT clients presenting with cough  Essential to offer same day screening for TB for persons with cough at HIV VCT centers  Patients with TB and cough can be rapidly identified for:  Treatment and  Prevention of TB transmission to immuno-compromised patients in waiting rooms  Patients dually infected with TB and HIV can be placed on isoniazid prophylaxis to prevent active TB Burgess A et al, AIDS:15:

Screening of adults with cough for TB at GHESKIO VCT YEARN Screened for HIV N with Cough N with TB 20019,7431, ,1101, ,8082, ,4111, ,4821, TOTAL72,5548,0432,324 30% of all with cough have active TB30% of all with cough have active TB 55% of active TB cases are HIV+55% of active TB cases are HIV+

HIV seroprevalence in TB and non-TB Adult Patients in MOH-GHESKIO Network in 2006 TB Centers % HIV+ VCT centers % HIV+ NETWORK232/ / GHESKIO290/ / TOTAL522/ /

Tuberculosis prevention in persons co-infected with HIV and TB Rate of active tuberculosis cases per 100 person-years PlaceboIntervention Author/Place/Date Pape et al/Haiti/1993 INH, X 1 year101.7 Markowitz et al/USA/1997 INH, X 6 mo Whalen et al/Uganda/1997 INH, X 6 mo INH+RIF, X 3 mo INH+RIF+PZA, X 3 mo Halsey et al/Haiti/1999 INH, 2X/week, X 6 mo-1.0 RIF +PZA, X 8 weeks-3.7 INH = Isoniasid ;RIF = Rifampin; PZA = Pyrazinamide

Effect of preventive INH on the incidence of active and progression of HIV infection Pape JW et al: The Lancet 342: 1993

MDR-TB et VIH Primary TBRecurrent TB HIV+11/115 (10%)- HIV-5/166 (3%)- RR=3.2, p=0.03 TOTAL16/281 (6%)10/49 (20%) 330 strains of mycobacterium tuberculosis during a 2 year period Joseph, P et al, AIDS 2006, 20: In collaboration with Institut Pasteur de Guadeloupe

Outcome of integration of HIV and TB From January 2005 to December 2006 in the MOH-GHESKIO network: At VCT centers: – 9199 HIV-infected patients were evaluated for TB; 2395 (26%)of them received care for TB –2126 patients HIV positive received INH prophylaxis 3768 patients with tuberculosis were tested for HIV; –1213 (32%) of them were HIV positive

HIV/TB Challenges for Haiti Interactions HIV/TB –HIV rate is 2-4 X higher in TB patients –Risk of developing active TB is 10X higher in HIV+. –INH prophylaxis and ART are both effective to prevent active TB in HIV+ TB diagnosis : majority of TB patients are smear negative. Must do CXR Most TB centers are staffed by nurses and auxiliary nurses ART and TB therapy is complex –Preferable not to start HIV and TB therapy at the same time to avoid IRS –High toxicity, mortality; abandon rate, recurrence rate MDRTB: higher association with HIV+  Necessity to develop joint HIV/TB national programs 1) Necessity to screen for HIV in all TB centers and 2) Screen for TB at VCT centers.  HIV+ and PPD+ should have a CXR and sputum smear to rule out active TB  Place on TB therapy those with active TB and on INH those who do not have active TB  HIV+ should receive INH + RIF during entire duration of therapy 3) Develop joint ART/TB training for care of HIV + patients requiring both 4) Need to develop new category of medical staff: Physician assistant 5) Must develop effective referral system between HIV and TB centers 6) Need to have nationwide survey on importance of MDRTB and new centers to care for MDRTB

Perspectives Complete integration between the national HIV and TB programs is necessary to curb both epidemics. With PEPFAR support, plan to create at a public TB site (Siguenau): –Unit for HIV/TB management –Unit for MDRTB treatment